Mindfulness intervention for women facing infertility treatments
Official title: What is the Impact of an E-tool Based Mindfulness Intervention on Psychological Outcomes Compared to no Intervention in Infertile Women Undergoing Assisted Reproductive Technique Treatments: A Randomized Controlled Study?
Run by University Hospital, Geneva · NCT04419740 · Data updated 2026-11-12
This study is testing whether a mindfulness app can help women dealing with infertility treatments feel less anxious and improve their overall well-being during IVF.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 42 Years |
| Sex | Women only |
| Enrollment | 150 (estimated) |
| Sponsor | University Hospital, Geneva Academic / other |
| Locations | 1 site (Geneva) |
| Status | Recruiting |
| Started | October 1, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | March 27, 2026 |
| Trial ID | NCT04419740 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are French-speaking women aged 18-42 who are scheduled for their first IVF treatment at the University Hospitals of Geneva.
✕Probably not a fit
Patients currently on psychotropic medication or undergoing psychiatric treatment may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a mindfulness application designed for women undergoing assisted reproductive techniques (ART) to help manage anxiety and improve psychological well-being. Participants in the treatment group will engage in daily 15-minute mindfulness meditation exercises during their IVF treatment, while the control group will receive standard care. The study aims to measure changes in anxiety, depression, quality of life, and mindfulness, as well as the potential impact on pregnancy rates and stress levels. By addressing psychological distress, the study seeks to enhance the overall experience and outcomes for women facing infertility.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the mental health and pregnancy outcomes for women undergoing infertility treatments.
How similar studies have gone: Preliminary evidence suggests that mindfulness-based interventions have shown promise in reducing mental health distress in similar populations, although results regarding pregnancy outcomes remain inconclusive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Participants fulfilling all of the following inclusion criteria are eligible for the study: * French-speaking * Women between the ages of 18-42 years * Scheduled for the first IVF treatment in HUG/CHUV/CPMA Lausanne * Access to a computer/smartphone/tablet with access to internet and a valid Email address * Informed Consent as documented by her signature on the form (Appendix Informed Consent Form) Exclusion Criteria: * Psychotropic medication * Ongoing psychiatric/psychological treatment * Known severe psychiatric co-morbidity
Where it's running
-
University Hospitals of Geneva
Geneva, Switzerland Recruiting
Study contacts
- Study coordinator: Noemie SACHS GUEDJ, MD
- Email: noemie.guedj@hug.ch
- Phone: +41795538546
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI into Ultrasound Diagnostics in Reproductive Medicine
Researchers are testing AI tools that analyze transvaginal ultrasound images to help detect endometriosis, adenomyosis, uterine masses, and pregnancy-related receptivity in women aged 18-45.
-
Tadalafil to increase uterine lining and improve frozen embryo transfer success
This test sees if adding daily tadalafil to standard estrogen helps women with unexplained infertility using good-quality day‑5 frozen embryos get a thicker uterine lining and better transfer outcomes.
-
FET-LET-2x2: Testing natural vs medicated natural cycles for frozen embryo transfer
This study tests four approaches to preparing the uterus for frozen embryo transfer to see which yields the best pregnancy rate in women undergoing IVF.
-
Integrative care guided by biological aging markers for unexplained female infertility
This trial tests whether measuring telomeres and other biological aging markers can guide a personalized integrative treatment to help women aged 25–42 with persistent unexplained infertility improve their chances of pregnancy.
-
How fitness, heart health, and mental well-being relate to assisted fertility treatments
This study tries to see if physical activity, cardiorespiratory fitness, cardiovascular health, sleep, and stress affect pregnancy chances for women undergoing assisted fertility treatments.
-
How attitudes toward artificial intelligence relate to anxiety and quality of life in women receiving infertility treatment
This study will test whether women's attitudes toward artificial intelligence are linked to their anxiety and quality of life while undergoing infertility treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.